Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04689256 · ClinicalTrials.gov registry record · NA
Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke
A NA study, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04689256 is a NA study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 4 participants.
The verdict
NCT04689256, a NA study, was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this clinical pilot study is to evaluate the effects of the MR-010 on tolerability, biomechanics and walking speed in the acute stroke care setting in addition to its impact on length of stay.
Interventions
- DEVICE MR-010
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-11-03 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04689256
The ClinicalTrials.gov registry entry for NCT04689256 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR-010 is the first listed.
NCT04689256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04689256 about?
NCT04689256 is a clinical study titled "Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke". The purpose of this clinical pilot study is to evaluate the effects of the MR-010 on tolerability, biomechanics and walking speed in the acute stroke care setting in addition to its impact on length of stay.
What is the current status of trial NCT04689256?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-11-03. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT04689256?
The interventions under investigation include: MR-010 (DEVICE).
Who is sponsoring clinical trial NCT04689256?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.